Skip to main content
Clinical Trials/CTRI/2022/03/040862
CTRI/2022/03/040862Not yet recruitingPhase 1

A Single arm clinical study to assess efficacy of Dadimadi Ghruta as an add on therapy in chemotherapy induced anemia

Dr Komal Shriram Indulkar0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Post Chemotherapy patients on hematinic for one month without significant change in hemoglobin level
  • hemoglobin in female less than 12 gm/dl
  • hemoglobin in male less than 13.5 gm/dl

Exclusion Criteria

  • Patients contra indicated for snehapana
  • Patients having thalassemia, sickle cell anemia and leukemia
  • Patients with low hemoglobin levels before chemotherapy

Investigators

Sponsor
Dr Komal Shriram Indulkar

Similar Trials